G1 Therapeutics, Inc. (GTHX) Financials

GTHX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2024 98.7 million 74.1 million
March 31, 2024 102.0 million 74.3 million
Dec. 31, 2023 121.5 million 86.2 million
Sept. 30, 2023 133.1 million 90.1 million

GTHX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2024 -5.3 million 2.1 million
March 31, 2024 -8.9 million 2.5 million
Dec. 31, 2023 -12.8 million 3.2 million
Sept. 30, 2023 -10.6 million 3.7 million

GTHX Net Income

No data available :(

GTHX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2024 60.8 million 32.9 million 3.6 million
March 31, 2024 65.2 million 37.1 million 4.0 million
Dec. 31, 2023 82.2 million 51.6 million 4.3 million
Sept. 30, 2023 94.4 million 4.7 million 4.7 million

GTHX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2024 52.5 million
March 31, 2024 52.2 million
Dec. 31, 2023 51.8 million
Sept. 30, 2023 51.8 million

GTHX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2024 - 5.7 million 13.6 million -
March 31, 2024 - 7.3 million 15.1 million -
Dec. 31, 2023 - 7.4 million 15.2 million -
Sept. 30, 2023 - 8.8 million 16.8 million -

GTHX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2024 16.5 million 733000
March 31, 2024 14.5 million 1.1 million
Dec. 31, 2023 14.9 million 1.3 million
Sept. 30, 2023 12.3 million 3.1 million

GTHX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

GTHX

Price: $7.16

52 week price:
1.08
7.19

Earnings Per Share: -0.86 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 586179

Ebitda: -15.9 million

Market Capitalization: 377.2 million

Links: